89 related articles for article (PubMed ID: 21416970)
1. [Progress in research of Chlamydia trachomatis plasmid protein pgp3].
Jia XH; Yang XL; Jia TJ
Sheng Li Ke Xue Jin Zhan; 2010 Dec; 41(6):467-70. PubMed ID: 21416970
[No Abstract] [Full Text] [Related]
2. Antiapoptotic activity of Chlamydia trachomatis Pgp3 protein involves activation of the ERK1/2 pathway mediated by upregulation of DJ-1 protein.
Luo F; Shu M; Gong S; Wen Y; He B; Su S; Li Z
Pathog Dis; 2019 Dec; 77(9):. PubMed ID: 31971555
[TBL] [Abstract][Full Text] [Related]
3. Chlamydia trachomatis plasmid-encoded protein Pgp3 inhibits apoptosis via the PI3K-AKT-mediated MDM2-p53 axis.
Zou Y; Lei W; Su S; Bu J; Zhu S; Huang Q; Li Z
Mol Cell Biochem; 2019 Feb; 452(1-2):167-176. PubMed ID: 30132214
[TBL] [Abstract][Full Text] [Related]
4. Serological response to pgp3 protein in animal and human chlamydial infections.
Donati M; Laroucau K; Storni E; Mazzeo C; Magnino S; Di Francesco A; Baldelli R; Ceglie L; Renzi M; Cevenini R
Vet Microbiol; 2009 Mar; 135(1-2):181-5. PubMed ID: 18945555
[TBL] [Abstract][Full Text] [Related]
5. Comparative PCR-based restriction fragment length polymorphism analysis of the plasmid gene orf3 of Chlamydia trachomatis and Chlamydia psittaci.
Storni E; Donati M; Marangoni A; Accardo S; Cevenini R
FEMS Immunol Med Microbiol; 2006 Dec; 48(3):313-8. PubMed ID: 16999825
[TBL] [Abstract][Full Text] [Related]
6. Chlamydial Plasmid-Dependent Pathogenicity.
Zhong G
Trends Microbiol; 2017 Feb; 25(2):141-152. PubMed ID: 27712952
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection.
Comanducci M; Manetti R; Bini L; Santucci A; Pallini V; Cevenini R; Sueur JM; Orfila J; Ratti G
Infect Immun; 1994 Dec; 62(12):5491-7. PubMed ID: 7960130
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Pgp3, a Chlamydia trachomatis plasmid-encoded immunodominant antigen.
Chen D; Lei L; Lu C; Galaleldeen A; Hart PJ; Zhong G
J Bacteriol; 2010 Nov; 192(22):6017-24. PubMed ID: 20851898
[TBL] [Abstract][Full Text] [Related]
9. Virulence Protein Pgp3 Is Insufficient To Mediate Plasmid-Dependent Infectivity of Chlamydia trachomatis.
Turman BJ; Alzhanov D; Nagarajan UM; Darville T; O'Connell CM
Infect Immun; 2023 Feb; 91(2):e0039222. PubMed ID: 36722979
[TBL] [Abstract][Full Text] [Related]
10. The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis.
Chen C; Chen D; Sharma J; Cheng W; Zhong Y; Liu K; Jensen J; Shain R; Arulanandam B; Zhong G
Infect Immun; 2006 Aug; 74(8):4826-40. PubMed ID: 16861671
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of an enzyme-linked immunosorbent assay for the detection of antibodies to a common urogenital derivative of Chlamydia trachomatis plasmid-encoded PGP3.
Winstanley CE; Ramsey KH; Marsh P; Clarke IN
J Immunol Methods; 2017 Jun; 445():23-30. PubMed ID: 28283408
[TBL] [Abstract][Full Text] [Related]
12. Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner.
Li Z; Zhong Y; Lei L; Wu Y; Wang S; Zhong G
BMC Microbiol; 2008 Jun; 8():90. PubMed ID: 18541036
[TBL] [Abstract][Full Text] [Related]
13. The Plasmid-Encoded pGP3 Promotes
Zhang T; Huo Z; Ma J; He C; Zhong G
Infect Immun; 2019 Mar; 87(5):. PubMed ID: 30858342
[TBL] [Abstract][Full Text] [Related]
14. Assessment and utility of 2 Chlamydia trachomatis Pgp3 serological assays for seroprevalence studies among women in the United States.
Danavall DC; Gwyn S; Anyalechi GE; Bowden KE; Hong J; Kirkcaldy RD; Bernstein KT; Kersh EN; Martin D; Raphael BH
Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115480. PubMed ID: 34325205
[TBL] [Abstract][Full Text] [Related]
15. [Chlamydia trachomatis proteasome protein as one of the significant pathogenicity factors of exciter].
Davydov DIu; Zigangirova NA
Mol Gen Mikrobiol Virusol; 2014; (2):3-8. PubMed ID: 25080811
[TBL] [Abstract][Full Text] [Related]
16. Chlamydial plasmid-encoded virulence factor Pgp3 neutralizes the antichlamydial activity of human cathelicidin LL-37.
Hou S; Dong X; Yang Z; Li Z; Liu Q; Zhong G
Infect Immun; 2015 Dec; 83(12):4701-9. PubMed ID: 26416907
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the reproducibility of a serological test for antibodies to Chlamydia trachomatis pgp3: A potential surveillance tool for trachoma programs.
Kaur H; Dize L; Munoz B; Gaydos C; West SK
J Microbiol Methods; 2018 Apr; 147():56-58. PubMed ID: 29501689
[TBL] [Abstract][Full Text] [Related]
18.
Huo Z; He C; Xu Y; Jia T; Wang J; Zhong G
Infect Immun; 2020 May; 88(6):. PubMed ID: 32205401
[TBL] [Abstract][Full Text] [Related]
19. Evolution of Chlamydia trachomatis.
Clarke IN
Ann N Y Acad Sci; 2011 Aug; 1230():E11-8. PubMed ID: 22239534
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia trachomatis Pgp3 Antibody Persists and Correlates with Self-Reported Infection and Behavioural Risks in a Blinded Cohort Study.
Horner PJ; Wills GS; Righarts A; Vieira S; Kounali D; Samuel D; Winston A; Muir D; Dickson NP; McClure MO
PLoS One; 2016; 11(3):e0151497. PubMed ID: 26974653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
